201 related articles for article (PubMed ID: 3449135)
1. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
[TBL] [Abstract][Full Text] [Related]
2. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
Marangoni R; Civardi F; Masi F; Avanzi C; Savino R; Manfredi A; Cimino R
Biomater Artif Cells Artif Organs; 1990; 18(4):541-8. PubMed ID: 2285819
[TBL] [Abstract][Full Text] [Related]
3. The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.
Li J; Li D; Xu Y; Wang A; Xu C; Yu C
Ren Fail; 2015 Feb; 37(1):103-7. PubMed ID: 25421427
[TBL] [Abstract][Full Text] [Related]
4. Use of combined hemodialysis/hemoperfusion in chronic uremia.
Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
[TBL] [Abstract][Full Text] [Related]
5. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
Bonomini V; Stefoni S; Casciani CU; Taccone Gallucci M; Albertazzi A; Cappelli P; Mioli V; Boggi R; Mastrangelo F; Rizzelli S
Contrib Nephrol; 1982; 29():133-42. PubMed ID: 7075212
[TBL] [Abstract][Full Text] [Related]
6. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.
Winchester JF; Ratcliffe JG; Carlyle E; Kennedy AC
Kidney Int; 1978 Jul; 14(1):74-81. PubMed ID: 682427
[TBL] [Abstract][Full Text] [Related]
7. Removal of endogenous middle molecules by hemoperfusion.
Asaba H; Bergström J; Fürst P; Gunnarsson B; Neuhauser M; Oulès R; Yahiel V
Artif Organs; 1979 May; 3(2):132-6. PubMed ID: 533396
[TBL] [Abstract][Full Text] [Related]
8. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
9. A purification method by uncoated charcoal.
Cerulli N; Politi L; D'Angelo AR; Scandurra R
Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
[No Abstract] [Full Text] [Related]
10. Evaluation of a new coated charcoal for hemoperfusion in uremia.
Stefoni S; Feliciangeli G; Coli L; Bonomini V
Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374
[TBL] [Abstract][Full Text] [Related]
11. Hemoperfusion with uncoated amberlite XE-336 resin in normal and uremic dogs.
Rosenbaum JL; Kramer MS; Raja R
Nephron; 1978; 21(1):27-37. PubMed ID: 662054
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Combination of Hemodialysis and Hemoperfusion on Clearing Advanced Glycation End Products: A Prospective, Randomized, Two-Stage Crossover Trial in Patients Under Maintenance Hemodialysis.
Zhang Y; Mei CL; Rong S; Liu YY; Xiao GQ; Shao YH; Kong YZ
Blood Purif; 2015; 40(2):127-32. PubMed ID: 26160062
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
14. Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial.
Tiranathanagul K; Khemnark N; Takkavatakarn K; Limjariyakul M; Mahatanan N; Chariyavilaskul P; Wittayalertpanya S; Susantitaphong P; Eiam-Ong S
Artif Organs; 2022 May; 46(5):775-785. PubMed ID: 35028951
[TBL] [Abstract][Full Text] [Related]
15. Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.
Stefoni S; Colì L; Feliciangeli G; Scolari MP; Bonomini V
Int J Artif Organs; 1986 Sep; 9(5):297-300. PubMed ID: 3781660
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
Trznadel K; Walasek L; Kidawa Z; Lutz W
Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
[TBL] [Abstract][Full Text] [Related]
17. The use of hemoperfusion as an adjunct to hemodialysis.
Trafford A; Ireland R; Evans R
Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415
[TBL] [Abstract][Full Text] [Related]
18. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I
Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586
[TBL] [Abstract][Full Text] [Related]
19. Sorbent membrane dialysis in uremia.
Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
[TBL] [Abstract][Full Text] [Related]
20. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
